VHBio is not supported on Internet Explorer and will not provide you with the best experience. Please consider switching to a compatible browser such as Microsoft Edge, Google Chrome or Firefox.
The QuantideX BCR-ABL IS Kit provides labs with a robust and reliable method for monitoring leukaemia patients, also allowing them to keep pace with the advances in TKI therapy. Reduced Complexity | Ease-of-data analysis and reporting: Direct reporting on the International Scale (IS): No sample exchange or conversion factor calculations required Data analysis software eliminates manual […]
The QuantideX BCR-ABL IS Kit provides labs with a robust and reliable method for monitoring leukaemia patients, also allowing them to keep pace with the advances in TKI therapy.
Figure 1: LOD as determined by CLSI EP-17A2 guidelines by testing Human RNA dilutions ranging from MR4.4 to MR6: 60 replicates of each dilution for a total of 1260 data points.
Minimal Variability Across Entire Dynamic Range of %IS Values
Figure 2. Precision was evaluated by using 5 different levels of positive specimen, tested by 3 operators over 20 runs. Each level was tested 40 times to obtain Standard Deviations.
Figure 3: Comparison of a plate layout for 8 sample run on Asuragen plate (left) and an alternate non-multiplex assay (right): 19 reactions for Asuragen set up vs 60-64 reaction on a non-multiplex assay set up
Quantidex® QPCR BCR-ABL IS Kit
14th April 2020
6th February 2020
14th February 2020
10th June 2020
16th June 2020
We work with a range of suppliers with novel and innovative products sourced from our global partners.Find Products